|
Real-time Estimate
Cboe BZX
10:37:51 30/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.875 USD | +0.27% |
|
-6.44% | +21.15% |
| 16/09 | Novartis halts ALS drug development after mid-stage trial failure | RE |
| 15/09 | Alector, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 07:00 AM |
| Market Cap | 21Cr 18Cr 17Cr 16Cr 30Cr 2TCr 30Cr 208.43Cr 80Cr 1.02TCr 78Cr 77Cr 3.28TCr | P/E 2026 * |
-2.17x | P/E 2027 * | -2.83x |
|---|---|---|---|---|---|
| Enterprise Value | -1.87Cr -1.64Cr -1.56Cr -1.41Cr -2.65Cr -179.01Cr -2.68Cr -19Cr -7.17Cr -92Cr -7.01Cr -6.86Cr -293.4Cr | EV / Sales 2026 * |
-1.7x | EV / Sales 2027 * | -3.14x |
| Free-Float |
90.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ALEC | Delayed | |
CBOE
| ALEC | Real-time | |
|
Deutsche Boerse AG
| 0Z2 | Delayed | |
|
Börse Stuttgart
| 0Z2 | Delayed | |
|
Tradegate
| 0Z2 | Real-time | |
|
Boerse Muenchen
| 0Z2 | Real-time |
Last Transcript: Alector, Inc.
| 1 day | +0.27% | ||
| 1 week | -6.44% | ||
| Current month | -16.37% | ||
| 1 month | -16.37% | ||
| 3 months | -5.97% | ||
| 6 months | -6.44% | ||
| Current year | +21.15% |
| 1 week | 1.83 |  | 2.05 |
| 1 month | 1.79 | | 2.76 |
| Current year | 1.37 | | 2.76 |
| 1 year | 1.09 | | 3.4 |
| 3 years | 0.87 | | 8.9 |
| 5 years | 0.87 | | 27 |
| 10 years | 0.87 | | 43.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arnon Rosenthal
CEO | Chief Executive Officer | 71 | 01/05/2013 |
Neil Berkley
DFI | Director of Finance/CFO | 52 | 20/06/2025 |
Hua Long
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Arnon Rosenthal
BRD | Director/Board Member | 71 | 01/05/2013 |
Richard Scheller
BRD | Director/Board Member | 72 | 01/10/2018 |
Louis Lavigne
CHM | Chairman | 77 | 13/06/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/09/26 | Sell | Controller/Auditor | -3,625 | 0.0032% | ||
| 03/09/26 | Sell | Chief Financial Officer | -29,251 | 0.0262% | ||
| 03/09/26 | Sell | Founder | -72,606 | 0.0650% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.27% | -6.44% | -36.15% | -69.47% | 21Cr | |
| +4.16% | -0.30% | +58.96% | +94.17% | 7.15TCr | |
| -0.19% | +1.32% | +37.20% | +81.33% | 6.01TCr | |
| -1.51% | +2.39% | +9.10% | +36.79% | 4.89TCr | |
| +0.80% | +1.25% | +42.79% | +39.89% | 4.43TCr | |
| +1.41% | +8.79% | +344.35% | +692.93% | 4.38TCr | |
| +1.84% | +1.96% | +9.23% | +108.49% | 4.15TCr | |
| -0.67% | -0.45% | +4.47% | +46.37% | 3.01TCr | |
| +4.77% | +6.46% | +41.54% | +22.78% | 2.8TCr | |
| +0.53% | -1.83% | -19.33% | +357.94% | 2.53TCr | |
| Average | +1.16% | -0.27% | +49.22% | +141.12% | 3.94TCr | |
| Weighted average by Cap. | +1.33% | +0.62% | +63.68% | +155.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.1Cr 96.61L 91.54L 82.64L 1.56Cr 105.2Cr 1.58Cr 11Cr 4.21Cr 54Cr 4.12Cr 4.03Cr 172.42Cr | 2.8Cr 2.47Cr 2.34Cr 2.11Cr 3.98Cr 268.55Cr 4.03Cr 28Cr 11Cr 137.29Cr 11Cr 10Cr 440.16Cr |
| Net income | -9.75Cr -8.59Cr -8.14Cr -7.35Cr -14Cr -935.03Cr -14Cr -97Cr -37Cr -478Cr -37Cr -36Cr -1.53TCr | -9.73Cr -8.57Cr -8.12Cr -7.33Cr -14Cr -933.38Cr -14Cr -97Cr -37Cr -477.16Cr -37Cr -36Cr -1.53TCr |
| Net Debt | -23Cr -20Cr -19Cr -17Cr -32Cr -2.18TCr -33Cr -227.07Cr -87Cr -1.11TCr -85Cr -84Cr -3.57TCr | -30Cr -26Cr -25Cr -22Cr -42Cr -2.85TCr -43Cr -296.24Cr -114Cr -1.45TCr -111.44Cr -109Cr -4.66TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $1.875 | +0.27% | 3,66,526 |
| 29/26/29 | $1.870 | -2.60% | 9,60,739 |
| 28/26/28 | $1.920 | -1.54% | 7,13,343 |
| 25/26/25 | $1.950 | +1.56% | 10,24,565 |
| 24/26/24 | $1.920 | -4.95% | 8,49,547 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALEC Stock
Select your edition
All financial news and data tailored to specific country editions
